Smita Patel

Smita Patel is an experienced professional in the field of drug safety and pharmacovigilance, currently serving as Associate Director at Genmab since November 2022, where oversight of FDA filings and approvals for the Epinkly drug has contributed to $3.2 billion in revenue within nine months for diffuse large B-cell lymphoma patients. Prior to this role, Smita held the position of Sr. Clinical Safety Analyst at AbbVie from January 2015 to October 2022, leading safety profile evaluations for Venetoclax in chronic lymphocytic leukemia patients and ensuring data integrity during clinical trials. Smita's background also includes roles as a Registered Nurse at Lexington Health Network and Elmwood Care, providing patient care, medication administration, and hemodynamic monitoring. Additional experience includes positions at Teva Pharmaceuticals, Johnson & Johnson, and Baxter International, focusing on supply chain quality assurance and complaint analysis. Smita holds two Bachelor's degrees from Loyola University Chicago in Biochemistry and Registered Nursing.